-
-
-
-
-
-
-
DURECT Corporation Announces Outcome of FDA Advisory Committee Meeting for POSIMIR®
-
-
-
-
-
-
-
DURECT Corporation Announces Positive Results from the Phase 2a Clinical Trial of DUR-928 in Alcoholic Hepatitis Patients in a Late-Breaking Presentation at The Liver Meeting®
-
-
-
-
-
-
-
DURECT Corporation Announces First Quarter 2018 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
DURECT Provides REMOXY® Update
-
-
-
-
13,127 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All